Jeff Yass’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.15M Buy
137,000
+108,900
+388% +$3.34M ﹤0.01% 4785
2026
Q2
$976K Sell
28,100
-700
-2% -$20.7K ﹤0.01% 8260
2026
Q1
$664K Buy
+28,800
New +$650K ﹤0.01% 8923
2025
Q4
– Sell
-33,000
Closed -$609K – 13817
2025
Q3
$609K Buy
+33,000
New +$648K ﹤0.01% 8513

Other funds holding AVBP

Jeff Yass's AVBP Position: Q3 2026 in Review

Jeff Yass sold out of ArriVent BioPharma (AVBP) in Q3 2026, closing a stake of 28,582 shares — an estimated $876K sold.

Jeff Yass first reported a position in AVBP in Q4 2024 and held it in 6 quarters. The position peaked at $4.89M in Q4 2025. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • Jeff Yass reported no remaining ArriVent BioPharma position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 28,582 ArriVent BioPharma shares in Q3 2026, an estimated $876K.
  • Jeff Yass first reported a position in ArriVent BioPharma in Q4 2024 and held it in 6 quarters.
  • Jeff Yass's ArriVent BioPharma position peaked at $4.89M in Q4 2025.
  • 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.